A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects

NCT02163278 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: DBPR108
DRUG: matching placebo

Sponsor

National Health Research Institutes, Taiwan